Cooper University Hospital is a teaching hospital and biomedical research facility located in Camden, New Jersey. The hospital formerly served as a clinical campus of Robert Wood Johnson Medical School and the University of Medicine and Dentistry of New Jersey.

There are 635 beds in Cooper Univ. Hosp. CRS.

During the past decade, Cooper Univ. Hosp. CRS conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cooper Univ. Hosp. CRS" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "AIDS Clinical Trials Group" with 1 trials as a collaborator and "Adult AIDS Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Cooper Univ. Hosp. CRS" are "HIV Infections" (11 trials), "Cardiovascular Diseases" (1 trials), "HIV Infection" (1 trials), "Hepatitis C" (1 trials) and "Herpes Zoster" (1 trials). Many other conditions were trialed in "Cooper Univ. Hosp. CRS" in a lesser frequency.

Most popular intervention types in "Cooper Univ. Hosp. CRS" are "Drug" (7 trials), "Biological" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darunavir" (2 trials), "Placebo" (2 trials), "Raltegravir" (2 trials), "Atazanavir" (1 trials) and "Boceprevir (BOC)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cooper Univ. Hosp. CRS" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cooper Univ. Hosp. CRS". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Cooper Univ. Hosp. CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cooper Univ. Hosp. CRS, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".